Latest
 
  • All Share : 49753.29
    UP 0.25%
    Top40 - (Tradeable) : 44453.51
    UP 0.36%
    Financial 15 : 14669.69
    UP 0.88%
    Industrial 25 : 69725.15
    UP 0.11%
    Resource 10 : 26091.75
    UP 0.16%

  • ZAR/USD : 15.9945
    DOWN -0.17%
    ZAR/GBP : 23.1717
    DOWN -0.04%
    ZAR/EUR : 17.8083
    DOWN -0.21%
    ZAR/JPY : 0.136
    DOWN -0.51%
    ZAR/AUD : 11.3379
    UP 0.23%

  • Gold US$/oz : 1173.5
    UNCHANGED0.00%
    Platinum US$/oz : 910
    UNCHANGED0.00%
    Silver US$/oz : 15.01
    UNCHANGED0.00%
    Palladium US$/oz : 502
    UNCHANGED0.00%
    Brent Crude : 34.06
    UNCHANGED0.00%

  • All data is delayed by 15 min. Data supplied by Profile Data
    Hover cursor over this ticker to pause.

Send Mail

Melanoma drug nearly doubles survival time: study

A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average survival time in a study of more than 130 patients, researchers said.

AFP Relaxnews

 24 February, 2012 10:45
* Required